All News #Library
Rare Diseases
Eidos Therapeutics raises $106M IPO to advance ATTR med
20 Jun 2018 //
FIERCE BIOTECH
Rare disease biotech Eidos Therapeutics sets terms for $100 million IPO
08 Jun 2018 //
NASDAQ

Market Place
Sourcing Support